Scientists test new Drug-Radiation combo in fight against tough sarcomas
NCT ID NCT02787642
Summary
This early-stage study tested whether adding a drug called olaparib to standard radiation therapy is safe and might help control advanced soft-tissue sarcomas that cannot be surgically removed. It involved 41 adults with these difficult-to-treat tumors. The main goal was to find the highest safe dose of olaparib to give alongside radiation, while also checking if the combination could stop tumor growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard
Lyon, 69373, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Claudius Regaud - IUCT
Toulouse, 31052, France
-
Institut du Cancer de Montpellier
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.